Package 67457-316-25

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 67457-316-25
Digits Only 6745731625
Product NDC 67457-316
Description

1 VIAL in 1 CARTON (67457-316-25) / 20 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2018-10-10
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "b47bee52-7718-749c-e053-2a95a90a0f38", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["447a9fbd-106d-4ff6-8fd0-bb38a8c90e17"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (67457-316-25)  / 20 mL in 1 VIAL", "package_ndc": "67457-316-25", "marketing_start_date": "20181010"}], "brand_name": "Decitabine", "product_id": "67457-316_b47bee52-7718-749c-e053-2a95a90a0f38", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "67457-316", "generic_name": "decitabine", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Decitabine", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/20mL"}], "application_number": "ANDA204607", "marketing_category": "ANDA", "marketing_start_date": "20181010", "listing_expiration_date": "20261231"}